Antibacterial Maker Raises $70 Million

Targanta Therapeutics Inc., a Cambridge, Mass.-based developer of antibacterial agents, has raised $70 million in Series C funding. Brookside Capital, Skyline Ventures, Radius Ventures and OrbiMed Advisors were joined by return backers like Seaflower Ventures, VenGrowth Advanced Life Sciences Fund and the Canadian Medical Discoveries Fund. www.targanta.com < ?xml:namespace prefix = o ns = "urn:schemas-microsoft-com:office:office" />